If you search the prescribing information for semaglutide (Ozempic and Wegovy) or tirzepatide (Zepbound and Mounjaro) for the word "alcohol," the only hits are an inactive ingredient and the old name of a liver disease [1] [2]. There is no rule about drinking. That doesn't make drinking risk-free on these drugs, because some of their warnings overlap with what alcohol does. Here is what the labels say, and where metformin is different.
The GLP-1 labels set no rule about drinking
The current labels for all four brand drugs contain no instruction, warning or limit on alcohol [3] [2] [1] [4]. That is also true of the Wegovy pill, which shares a label with the Wegovy injection. Metformin, by contrast, names alcohol in its boxed warning.
| Drug | Alcohol warning? | Related warnings that matter if you drink |
|---|---|---|
| Ozempic (semaglutide) | None | Pancreatitis; kidney injury from dehydration; low blood sugar with insulin or a sulfonylurea |
| Wegovy injection and pill (semaglutide) | None | Pancreatitis; kidney injury from dehydration; low blood sugar |
| Zepbound (tirzepatide) | None | Pancreatitis; kidney injury from dehydration; low blood sugar |
| Mounjaro (tirzepatide) | None | Pancreatitis; kidney injury from dehydration; low blood sugar with insulin or a sulfonylurea |
| Metformin | Yes: excessive alcohol raises the risk of lactic acidosis | Low blood sugar; dehydration |
Current prescribing information for each drug [3] [2] [1] [4] [5].
No trial has tested how alcohol changes a GLP-1's results, so there is no evidence either way on whether drinking blunts weight loss. What the labels do give you is a set of warnings worth reading with alcohol in mind.
Pancreatitis: a GLP-1 warning, and heavy drinking is a common cause
Every GLP-1 label carries a pancreatitis warning. Zepbound's says acute pancreatitis, "including fatal and non-fatal hemorrhagic or necrotizing pancreatitis," has been seen with these drugs, and it lists the signs to watch for: "persistent or severe abdominal pain (sometimes radiating to the back) and which may or may not be accompanied by nausea or vomiting" [1]. Ozempic's warning uses nearly the same words [3].
Alcohol enters the picture on its own. The National Institute of Diabetes and Digestive and Kidney Diseases lists heavy alcohol use among the most common causes of both acute and chronic pancreatitis, along with gallstones [6]. The GLP-1 labels don't say the two risks add up, and no trial has measured that. But if you have a history of pancreatitis or drink heavily, your prescriber needs to know before you start.
Gallstones are the other link. NIDDK names them as the most common cause of acute pancreatitis [6], and the GLP-1 labels carry a separate gallbladder warning. In Zepbound's weight trials, gallbladder inflammation (cholecystitis) was reported in 0.7% on Zepbound vs 0.2% on placebo, and the label says gallbladder events were associated with weight reduction [1]. So two of the main causes of pancreatitis, gallstones and heavy drinking, sit close to warnings already on these labels.
Dehydration: vomiting and diarrhea can strain the kidneys
Stomach side effects are the most common thing people feel on a GLP-1, and the labels connect them to a kidney warning. Zepbound's label reports acute kidney injury after approval, "in some cases requiring hemodialysis," and says most cases happened in people whose nausea, vomiting or diarrhea led to dehydration [1]. Ozempic's label says the same of semaglutide [3].
If you're already losing fluid to vomiting or diarrhea, that's the time to be most cautious about drinking. The labels also say when stomach effects peak: in Zepbound's weight trials, most nausea, vomiting and diarrhea happened during dose increases and eased over time [1]. The weeks after a dose change are the ones to be most careful with. More on managing the stomach side is in Ozempic stomach side effects and Wegovy and nausea.
Low blood sugar: mainly a risk with insulin or a sulfonylurea
The labels tie the biggest low-blood-sugar risk to taking a GLP-1 with insulin or a sulfonylurea. Ozempic's warns that people taking it with "an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia" [3]. Zepbound's and Wegovy's labels carry the same warning [1] [2].
The GLP-1 labels don't mention alcohol here, but metformin's patient guide does: it says low blood sugar "can happen if you do not eat enough, if you drink alcohol, or if you take other medicines to lower blood sugar" [5]. If you have diabetes and take more than one blood-sugar medicine, ask your prescriber how drinking fits with your plan.
Metformin is the one with a direct alcohol warning
Metformin's label is explicit. "Alcohol potentiates the effect of metformin on lactate metabolism. Patients should be warned against excessive alcohol intake," it says, and excessive alcohol intake is on its boxed-warning list of lactic-acidosis risk factors [5]. Lactic acidosis is rare, but it can be fatal.
Do not drink a lot of alcoholic drinks while taking metformin hydrochloride tablets or metformin hydrochloride extended-release tablets. This means you should not binge drink for short periods, and you should not drink a lot of alcohol on a regular basis. Alcohol can increase the chance of getting lactic acidosis.[5]
That's the patient Medication Guide. It doesn't say you must not drink at all, and it doesn't tell you to skip doses when you do; those are questions for your prescriber. For the rest of metformin's side effects, see metformin side effects, and for tiredness specifically, does metformin make you tired?
Do GLP-1s change how much people drink?
Whether GLP-1s change drinking is an open research question, and one small trial put it to a test. Researchers gave 48 adults with alcohol use disorder low doses of semaglutide or placebo for 9 weeks. Semaglutide reduced how much alcohol people drank in a lab drinking session, cut drinks per drinking day and lowered weekly craving [7].
It did not change average drinks per calendar day or the number of days people drank [7]. The authors call their results "initial prospective evidence" that justifies larger trials. No GLP-1 is approved to treat alcohol use disorder, and the trial used low doses.
Questions to ask your prescriber
- Where am I in my dose increases, and when are stomach side effects most likely?
- Do any of my other medicines, such as insulin or a sulfonylurea, raise my risk of low blood sugar if I drink?
- Does my history with pancreatitis, gallstones or liver problems change what's safe for me?
- If I take metformin too, what counts as excessive drinking for me?
For the full side-effect lists, see Zepbound side effects and is Mounjaro safe? If you're comparing the semaglutide forms, Wegovy pill vs injection covers how they differ.
See how the 88 compounded semaglutide providers we score compare on monthly cost and care.